Literature DB >> 20300981

Activated protein C resistance in the Japanese population due to homozygosity for the factor V R2 haplotype.

Hiromi Okada, Yoshimi Toyoda, Akira Takagi, Hidehiko Saito, Tetsuhito Kojima, Tomio Yamazaki.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20300981     DOI： 10.1007/s12185-010-0547-3

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  7 in total

Review 1.  Procoagulant and anticoagulant properties of coagulation factor V: factor V Leiden (APC resistance) causes hypercoagulability by dual mechanisms.

Authors:  B Dahlbäck
Journal:  J Lab Clin Med       Date:  1999-05

2.  Coagulation factor V Leiden mutation may have a racial background.

Authors:  H Fujimura; J Kambayash; M Monden; H Kato; T Miyata
Journal:  Thromb Haemost       Date:  1995-11       Impact factor: 5.249

3.  APC-resistance and Mnl I genotype (Gln 506) of coagulation factor V are rare in Japanese population.

Authors:  O Takamiya; F Ishida; H Kodaira; K Kitano
Journal:  Thromb Haemost       Date:  1995-09       Impact factor: 5.249

4.  The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.

Authors:  M C de Visser; J F Guasch; P W Kamphuisen; H L Vos; F R Rosendaal; R M Bertina
Journal:  Thromb Haemost       Date:  2000-04       Impact factor: 5.249

5.  A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype.

Authors:  F Bernardi; E M Faioni; E Castoldi; B Lunghi; G Castaman; E Sacchi; P M Mannucci
Journal:  Blood       Date:  1997-08-15       Impact factor: 22.113

6.  Mutation in blood coagulation factor V associated with resistance to activated protein C.

Authors:  R M Bertina; B P Koeleman; T Koster; F R Rosendaal; R J Dirven; H de Ronde; P A van der Velden; P H Reitsma
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

7.  Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.

Authors:  B Dahlbäck; M Carlsson; P J Svensson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.